Intel 18A-P Process Enters Risk Production, Enhancing Foundry Business
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Source: seekingalpha
- Process Advancement: Intel announced that its 18A-P process has entered risk production on schedule, highlighting the company's efforts to enhance manufacturing capabilities aimed at attracting external chip customers, thereby strengthening its market competitiveness.
- Performance Improvement: Compared to the 18A process, the 18A-P offers a 9% performance increase at iso-power or an 18% power reduction at iso-performance, which not only enhances the product's market appeal but may also influence customer purchasing decisions positively.
- Thermal Characteristics Optimization: The new process achieves a 20-40% improvement in thermal resistance through material and design innovations, enhancing thermal management capabilities and ensuring stability in high-performance applications, further boosting the product's competitive edge.
- Increased Design Flexibility: The new dual contact, low resistance transistor option of the 18A-P enables increased drive current and frequency while maintaining capacitance matching, which will help meet diverse customer needs and drive business growth.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy INTC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on INTC
Wall Street analysts forecast INTC stock price to fall
29 Analyst Rating
5 Buy
19 Hold
5 Sell
Hold
Current: 127.860
Low
20.00
Averages
39.30
High
52.00
Current: 127.860
Low
20.00
Averages
39.30
High
52.00
About INTC
Intel Corporation is a global designer and manufacturer of semiconductor products. The Company's segments include Intel Products, Intel Foundry, and All Other. Its Intel Products comprise Client Computing Group (CCG) and Data Center and AI (DCAI). CCG delivers platforms and processors that power PCs and edge devices, enabling enhanced performance, connectivity and user experience for consumer and commercial markets with capabilities that also support retail, industrial robotics and AI ecosystems at the edge. DCAI delivers workload-optimized solutions based upon its x86 architecture for data centers, including CPUs, AI accelerators, NICs, IPUs and custom ASICs, enabling performance and scalability for cloud, enterprise, telecommunication and HPC environments. The Intel Foundry segment comprises technology development, manufacturing and foundry services, developing new semiconductor process technologies and advanced packaging technologies. All Other segments include Mobileye and Other.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Intel's 18A Manufacturing Process Enters Risk Production Amid Strong Demand
- New Process Launch: Intel announced that its 18A manufacturing process has entered risk production, indicating the company's commitment to manufacturing and potentially attracting external customer interest, thereby enhancing its market competitiveness.
- Performance Improvement: Compared to 18A, the 18A-P delivers a 9% performance increase at the same power level or an 18% reduction in power consumption at the same processing speed, which will enhance product market appeal and meet customer demand for high-performance chips.
- Strong Customer Demand: In the first quarter, demand for Intel's central processors surged, particularly from companies offering AI services, leading to sales of chips that were originally slated for write-off, demonstrating strong market demand for its products.
- Revenue Forecast Upgrade: Intel forecasts second-quarter revenue between $13.8 billion and $14.8 billion, exceeding the market estimate of $13.07 billion, reflecting the company's robust performance in the rapidly growing AI market.
See More
Intel 18A-P Process Enters Risk Production, Enhancing Foundry Business
- Process Advancement: Intel announced that its 18A-P process has entered risk production on schedule, highlighting the company's efforts to enhance manufacturing capabilities aimed at attracting external chip customers, thereby strengthening its market competitiveness.
- Performance Improvement: Compared to the 18A process, the 18A-P offers a 9% performance increase at iso-power or an 18% power reduction at iso-performance, which not only enhances the product's market appeal but may also influence customer purchasing decisions positively.
- Thermal Characteristics Optimization: The new process achieves a 20-40% improvement in thermal resistance through material and design innovations, enhancing thermal management capabilities and ensuring stability in high-performance applications, further boosting the product's competitive edge.
- Increased Design Flexibility: The new dual contact, low resistance transistor option of the 18A-P enables increased drive current and frequency while maintaining capacitance matching, which will help meet diverse customer needs and drive business growth.
See More
Intellia Therapeutics Shows Significant Progress, Stock Up 58%
- Clinical Trial Resumption: Intellia Therapeutics successfully resumed its clinical trials after the FDA placed two phase 3 studies on hold, resulting in a 58% increase in stock price year-to-date, reflecting market confidence in its future potential.
- Gene Editing Therapy Progress: On April 27, Intellia announced phase 3 trial results for lonvo-z, showing an 87% reduction in attacks and 62% of patients completely free of attacks after a single infusion, indicating the therapy's potential to become the standard of care for HAE.
- Market Opportunity Assessment: Although there are only about 7,000 HAE patients, lonvo-z could represent a market opportunity of $7 billion, with an estimated lifetime sales of $3.5 billion assuming a 50% penetration rate, highlighting its commercial value.
- Future Development Prospects: Intellia is also developing nex-z for treating ATTR, with a global patient population of 250,000 to 500,000; if clinical trials succeed, it could significantly enhance the company's outlook and drive further stock price increases.
See More
Trump Pushes for Ukraine Deal Amid Iran Agreement Progress
- Iran Agreement Progress: The memorandum of understanding for the Iran deal is nearing signing in Geneva with no reversals from either side, indicating sustained diplomatic efforts that could ease tensions in the Middle East.
- Focus on Ukraine Conflict: At the G7 meeting, Trump pledged further support to Kyiv and urged Moscow to make a deal to end the conflict, although the multi-year war is unlikely to resolve quickly, reflecting the U.S.'s proactive foreign policy stance.
- Oil Price Reactions: Brent crude futures fell 5% to $78.96 per barrel due to expectations of sanctions relief for Iran, marking the first time it has dipped below $80, which reflects optimistic market sentiment regarding supply dynamics that could impact global energy markets.
- Market Dynamics: The Dow Jones Industrial Average reached a record high of 51,999.67, indicating a shift in investor preference towards cyclical stocks, while tech stocks declined as investors rotated out, showcasing changing market sentiments.
See More
Tech Stocks Retreat as SpaceX Surges to Fifth Most Valuable Company
- Tech Stock Retreat: Technology stocks experienced a broad decline on Tuesday, led by chip stocks, with Nvidia closing down over 2%, while Micron, AMD, and Broadcom also faced significant drops, indicating a cautious market sentiment as investors rotated out of highly valued tech shares into other sectors.
- SpaceX Market Surge: SpaceX finished its third trading day nearly 5% higher, becoming the fifth most valuable company in the U.S., surpassing Amazon's market value, which highlights the company's strong growth potential in the aerospace sector and may attract increased investor interest.
- Federal Reserve Policy Meeting: The Fed's two-day policy meeting commenced on Tuesday, with markets overwhelmingly expecting interest rates to remain unchanged, as indicated by a 99.4% probability from the CME FedWatch Tool, leading investors to closely monitor the meeting for guidance on future monetary policy directions.
- Strong Financial Sector Performance: The Financial Select Sector SPDR ETF closed nearly 1.5% higher, with Goldman Sachs, Morgan Stanley, and JPMorgan Chase all finishing in the green, demonstrating resilience and attractiveness in the financial sector amid market volatility.
See More
U.S. Stocks Close Mixed: Dow Hits All-Time High
- Dow Hits All-Time High: The Dow Jones Industrial Average rose by 0.64%, reaching a new all-time high, reflecting investor confidence in economic recovery, despite mixed overall market performance indicating divergent views among investors on various sectors.
- Chip Stocks Decline: With Marvell Technology and Intel falling over 9% and 8% respectively, the weakness in chipmakers weighed on the broader market, suggesting that the pressure on tech stocks may impact future investment sentiment.
- Weak Housing Data: U.S. May housing starts fell 15.4% month-over-month to a six-year low of 1.177 million, below expectations of 1.430 million, indicating that the weakness in the housing market could pose challenges to economic growth.
- Oil Prices Plummet: WTI crude oil prices dropped more than 5% to a 3.5-month low due to the U.S.-Iran agreement to reopen the Strait of Hormuz, enhancing expectations for a revival in oil supplies, which may affect the performance of energy stocks.
See More
Intel's 18A Manufacturing Process Enters Risk Production Amid Strong Demand
- New Process Launch: Intel announced that its 18A manufacturing process has entered risk production, indicating the company's commitment to manufacturing and potentially attracting external customer interest, thereby enhancing its market competitiveness.
- Performance Improvement: Compared to 18A, the 18A-P delivers a 9% performance increase at the same power level or an 18% reduction in power consumption at the same processing speed, which will enhance product market appeal and meet customer demand for high-performance chips.
- Strong Customer Demand: In the first quarter, demand for Intel's central processors surged, particularly from companies offering AI services, leading to sales of chips that were originally slated for write-off, demonstrating strong market demand for its products.
- Revenue Forecast Upgrade: Intel forecasts second-quarter revenue between $13.8 billion and $14.8 billion, exceeding the market estimate of $13.07 billion, reflecting the company's robust performance in the rapidly growing AI market.
See More
Intel 18A-P Process Enters Risk Production, Enhancing Foundry Business
- Process Advancement: Intel announced that its 18A-P process has entered risk production on schedule, highlighting the company's efforts to enhance manufacturing capabilities aimed at attracting external chip customers, thereby strengthening its market competitiveness.
- Performance Improvement: Compared to the 18A process, the 18A-P offers a 9% performance increase at iso-power or an 18% power reduction at iso-performance, which not only enhances the product's market appeal but may also influence customer purchasing decisions positively.
- Thermal Characteristics Optimization: The new process achieves a 20-40% improvement in thermal resistance through material and design innovations, enhancing thermal management capabilities and ensuring stability in high-performance applications, further boosting the product's competitive edge.
- Increased Design Flexibility: The new dual contact, low resistance transistor option of the 18A-P enables increased drive current and frequency while maintaining capacitance matching, which will help meet diverse customer needs and drive business growth.
See More
Intellia Therapeutics Shows Significant Progress, Stock Up 58%
- Clinical Trial Resumption: Intellia Therapeutics successfully resumed its clinical trials after the FDA placed two phase 3 studies on hold, resulting in a 58% increase in stock price year-to-date, reflecting market confidence in its future potential.
- Gene Editing Therapy Progress: On April 27, Intellia announced phase 3 trial results for lonvo-z, showing an 87% reduction in attacks and 62% of patients completely free of attacks after a single infusion, indicating the therapy's potential to become the standard of care for HAE.
- Market Opportunity Assessment: Although there are only about 7,000 HAE patients, lonvo-z could represent a market opportunity of $7 billion, with an estimated lifetime sales of $3.5 billion assuming a 50% penetration rate, highlighting its commercial value.
- Future Development Prospects: Intellia is also developing nex-z for treating ATTR, with a global patient population of 250,000 to 500,000; if clinical trials succeed, it could significantly enhance the company's outlook and drive further stock price increases.
See More
Trump Pushes for Ukraine Deal Amid Iran Agreement Progress
- Iran Agreement Progress: The memorandum of understanding for the Iran deal is nearing signing in Geneva with no reversals from either side, indicating sustained diplomatic efforts that could ease tensions in the Middle East.
- Focus on Ukraine Conflict: At the G7 meeting, Trump pledged further support to Kyiv and urged Moscow to make a deal to end the conflict, although the multi-year war is unlikely to resolve quickly, reflecting the U.S.'s proactive foreign policy stance.
- Oil Price Reactions: Brent crude futures fell 5% to $78.96 per barrel due to expectations of sanctions relief for Iran, marking the first time it has dipped below $80, which reflects optimistic market sentiment regarding supply dynamics that could impact global energy markets.
- Market Dynamics: The Dow Jones Industrial Average reached a record high of 51,999.67, indicating a shift in investor preference towards cyclical stocks, while tech stocks declined as investors rotated out, showcasing changing market sentiments.
See More
Tech Stocks Retreat as SpaceX Surges to Fifth Most Valuable Company
- Tech Stock Retreat: Technology stocks experienced a broad decline on Tuesday, led by chip stocks, with Nvidia closing down over 2%, while Micron, AMD, and Broadcom also faced significant drops, indicating a cautious market sentiment as investors rotated out of highly valued tech shares into other sectors.
- SpaceX Market Surge: SpaceX finished its third trading day nearly 5% higher, becoming the fifth most valuable company in the U.S., surpassing Amazon's market value, which highlights the company's strong growth potential in the aerospace sector and may attract increased investor interest.
- Federal Reserve Policy Meeting: The Fed's two-day policy meeting commenced on Tuesday, with markets overwhelmingly expecting interest rates to remain unchanged, as indicated by a 99.4% probability from the CME FedWatch Tool, leading investors to closely monitor the meeting for guidance on future monetary policy directions.
- Strong Financial Sector Performance: The Financial Select Sector SPDR ETF closed nearly 1.5% higher, with Goldman Sachs, Morgan Stanley, and JPMorgan Chase all finishing in the green, demonstrating resilience and attractiveness in the financial sector amid market volatility.
See More
U.S. Stocks Close Mixed: Dow Hits All-Time High
- Dow Hits All-Time High: The Dow Jones Industrial Average rose by 0.64%, reaching a new all-time high, reflecting investor confidence in economic recovery, despite mixed overall market performance indicating divergent views among investors on various sectors.
- Chip Stocks Decline: With Marvell Technology and Intel falling over 9% and 8% respectively, the weakness in chipmakers weighed on the broader market, suggesting that the pressure on tech stocks may impact future investment sentiment.
- Weak Housing Data: U.S. May housing starts fell 15.4% month-over-month to a six-year low of 1.177 million, below expectations of 1.430 million, indicating that the weakness in the housing market could pose challenges to economic growth.
- Oil Prices Plummet: WTI crude oil prices dropped more than 5% to a 3.5-month low due to the U.S.-Iran agreement to reopen the Strait of Hormuz, enhancing expectations for a revival in oil supplies, which may affect the performance of energy stocks.
See More
